Sirtuin-1 directly binds and deacetylates hepatic PCSK9 thereby promoting the inhibition of LDL receptor degradation

SIRT1 directly binds hepatic PCSK9 and decreases its activity by deacetylation, thereby enhancing LDL-cholesterol clearance by hepatic LDLR upregulation. Boosting circulating SIRT1 exerts atheroprotective effects in mice, with high levels associating with improved prognosis in patients with established ASCVD.

Authors

Institutions

Publication Details

Journal
Cardiovascular Research
Published
2025-07-14
DOI
https://doi.org/10.1093/cvr/cvaf087
Citations
2
Primary Topic
Sirtuins and Resveratrol in Medicine
Type
article
Field-Weighted Citation Impact
2.45

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sirtuin-1 directly binds and deacetylates hepatic PCSK9 thereby promoting the inhibition of LDL receptor degradation

Melroy Miranda, Bart Staels, Priyanka Adla, Srividya Velagapudi et al.
2 citations
Cardiovascular Research
Sirtuins and Resveratrol in Medicine
2.45
article

Sirtuin-1 directly binds and deacetylates hepatic PCSK9 thereby promoting the inhibition of LDL receptor degradation

Melroy Miranda, Bart Staels, Priyanka Adla, Srividya Velagapudi, Ravi Kumar Gutti, T F Luescher, Simon Kraler, Hyo‐Soo Kim, Francesco Paneni, Naresh Babu V. Sepuri, Giovanni G. Camici, Lucia Rohrer, Hyunduk Jang, Alexander Akhmedov, Slayman Obeid, Anne Tailleux, Jérôme Robert, Hwan Lee, S A Mohammed, S. Baki, Arnold von Eckardstein
article en
2 citations

Abstract

SIRT1 directly binds hepatic PCSK9 and decreases its activity by deacetylation, thereby enhancing LDL-cholesterol clearance by hepatic LDLR upregulation. Boosting circulating SIRT1 exerts atheroprotective effects in mice, with high levels associating with improved prognosis in patients with established ASCVD.

Cardiovascular ResearchVol. 121(9)
King's College London (GB), Institut Pasteur de Lille (FR), Harefield Hospital (GB), Seoul National University Hospital (KR), University of Hyderabad (IN), University Hospital of Zurich (CH), Molecular Partners (Switzerland) (CH), Biomedical Research Institute (US)
National Science Foundation, Amgen, Foundation for Cardiovascular Research, Novartis Foundation, National Research Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Ministry of Science, ICT and Future Planning, National Research Foundation of Korea, Schweizerische Herzstiftung, Novartis Stiftung für Medizinisch-Biologische Forschung, Universität Zürich, Holcim Stiftung zur Förderung der Wissenschaftlichen Fortbildung
Good health and well-being
Openalex Percentile: Top 11%
Sirtuins and Resveratrol in Medicine
2.45
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.